Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized Comparison of Vascular Healing of a Polymer-Free Biolimus-eluting BIOFREEDOM Stent With a Biodegradable-Polymer Sirolimus-eluting ORSIRO Stent in Patients With ST-segment Elevation Myocardial Infarction

Trial Profile

Randomized Comparison of Vascular Healing of a Polymer-Free Biolimus-eluting BIOFREEDOM Stent With a Biodegradable-Polymer Sirolimus-eluting ORSIRO Stent in Patients With ST-segment Elevation Myocardial Infarction

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Oct 2018

At a glance

  • Drugs Umirolimus (Primary)
  • Indications Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms OCT STEMI SOIX
  • Most Recent Events

    • 31 Oct 2018 New trial record
    • 25 Sep 2018 Results (n=59) assessing the changes in Malapposition after implantation of Biolimus-coated BioFreedom Stent or Sirolimus Eluting Orsiro Stent stent in patients with ST-segment Elevation Myocardial Infarction, presented at the 30th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top